The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
NCT02261025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 410
Last updated 2014-10-23
Summary
The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.
Conditions
- Hemodialysis
Interventions
- DRUG
-
acetylsalicylic acid
75-100mg,per day
Sponsors & Collaborators
-
Shanghai Jiao Tong University School of Medicine
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
More Related Trials
-
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
NCT01364779 ·Status: COMPLETED
-
Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient
NCT01045785 ·Status: UNKNOWN
-
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
NCT01768637 ·Status: COMPLETED ·Phase: PHASE1
-
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
NCT04381143 ·Status: RECRUITING ·Phase: PHASE4
-
Aspirin Effectiveness Study
NCT01113060 ·Status: UNKNOWN
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Chronic Kidney Disease (CKD) Platelet Study
NCT03649711 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
NCT02550717 ·Status: COMPLETED
-
The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia
NCT02846259 ·Status: UNKNOWN
-
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
NCT02520921 ·Status: COMPLETED ·Phase: PHASE4
-
Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis
NCT02055131 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
NCT00427271 ·Status: UNKNOWN ·Phase: PHASE4
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aspirin Dosing in Diabetic Patients
NCT01201785 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial
NCT07205250 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
NCT01212302 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
NCT00501059 ·Status: COMPLETED ·Phase: PHASE3